Drug Safety Executive Council (DSEC) - Drug Safety Executive Council

Organized by:

{@shortdesc}

{@title}
{@headline}

View Profile

Slide: {@currentrow} of {ds_RowCount} Previous

The Drug Safety Executive Council (DSEC) is a peer-to-peer membership of 2,000 drug safety leaders with the common objective of advancing the development of better and safer medicines. Learn More.

DSEC also manages a Technology Evaluation Consortium, made up of biopharmaceutical companies, that qualifies novel, preclinical safety platforms. Learn more at www.drugsafetycouncil.org.

Why Join DSEC?

		Regular membership is complimentary


		Engage in member-driven discussions, research, and presentations that will help you lead your organization to better decision making

		Network with other high-level executives at leading biopharmaceutical companies to drive change that will encourage business growth


		Membership is limited to leaders representing companies who develop small and large molecule pharmaceuticals

Featured Events & Content

OnDemand Webinar: FDA SEND Initiative

View and listen to this webinar from January 11, which featured an overview of the SEND Initaitive by Dr. Timothy Kropp and a follow-up question and answer session.

Dr. Ernie Bush to moderate a panel discussion at Predictive Toxicology Summit

Attend the panel discussion, "Predictive Toxicology Tools: Evaluation and Qualification of New Technology in Safety Assessment," on February 15, 2012 as part of the Predictive Toxicology Summit being held in London.

DSEC and Metanomics Health Announce Results of Technology Evaluation Consortium

Read the press release to learn more.

DSEC Announces Consortium to Evaluate Cardiac Ion Channel Panel

Read the press release to learn more about the consortium.

World Pharma Congress 2012 (June 5-7, Philadelphia, PA)

Learn more about this conference focused on the pre-clinical areas of early discovery, screening and safety assessments.

OnDemand: Technology Showcase - Metanomics Health

View the session that took place on December 15, 2011.